[Clinical pathway and expert consensus on the diagnosis and treatment of bone metastases from lung cancer (2025 edition)].
摘要
Bone metastasis from lung cancer is one of the common complications in patients with advanced lung cancer, which can lead to pathological fractures, spinal cord compression, bone surgery, bone radiotherapy, and other skeletal related events (SREs), severely affecting the quality of life and prognosis of patients. The Non-Small Cell Lung Cancer Committee of the Chinese Society of Clinical Oncology convened a multidisciplinary expert panel comprising specialists from respiratory medicine, oncology, orthopedics, radiation oncology, nuclear medicine, radiology, and oral and maxillofacial surgery to develop this consensus. It is based on domestic and international evidence-based medicine and clinical practice experience, and was formulated through repeated consultations and thorough discussions. The consensus provides nine recommendations from six perspectives: diagnosis, screening, treatment strategies, bone-targeted drug treatment strategies and management of adverse reactions, local treatment, and efficacy evaluation. These recommendations are intended for reference and used by relevant medical personnel. The development of this consensus aims to provide scientific and practical guidance for clinicians, with the expectation of improving the quality of life and prognosis of patients.